Literature DB >> 17262189

Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking.

Daniel De Backer, Fabio Silvio Taccone, Peter Radermacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17262189     DOI： 10.1007/s00134-006-0520-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  26 in total

1.  Myocardial substrate metabolism influences left ventricular energetics in vivo.

Authors:  C Korvald; O P Elvenes; T Myrmel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

2.  Levosimendan in septic cardiac failure.

Authors:  A Noto; M Giacomini; A Palandi; L Stabile; C Reali-Forster; G Iapichino
Journal:  Intensive Care Med       Date:  2004-12-03       Impact factor: 17.440

3.  Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.

Authors:  Andrea Morelli; Stefano De Castro; Jean-Louis Teboul; Mervyn Singer; Monica Rocco; Giorgio Conti; Leonardo De Luca; Emanuele Di Angelantonio; Alessandra Orecchioni; Natesa G Pandian; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

Review 4.  Dobutamine and the oxygen uptake/supply relationship in sepsis: from global to regional--nothing is simple and easy.

Authors:  J Vogt; H Reinelt; P Radermacher
Journal:  Intensive Care Med       Date:  1997-07       Impact factor: 17.440

5.  Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients?

Authors:  D De Backer; J Creteur; O Noordally; N Smail; B Gulbis; J L Vincent
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

6.  The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis.

Authors:  E Ruokonen; A Uusaro; E Alhava; J Takala
Journal:  Intensive Care Med       Date:  1997-07       Impact factor: 17.440

7.  Levosimendan is a mitochondrial K(ATP) channel opener.

Authors:  D M Kopustinskiene; P Pollesello; N E Saris
Journal:  Eur J Pharmacol       Date:  2001-10-12       Impact factor: 4.432

8.  The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects.

Authors:  Daniel De Backer; Jacques Creteur; Marc-Jacques Dubois; Yasser Sakr; Marc Koch; Colin Verdant; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

9.  Potassium-specific effects of levosimendan on heart mitochondria.

Authors:  Dalia M Kopustinskiene; Piero Pollesello; Nils-Erik L Saris
Journal:  Biochem Pharmacol       Date:  2004-09-01       Impact factor: 5.858

10.  Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock.

Authors:  Yasser Sakr; Marc-Jacques Dubois; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2004-09       Impact factor: 7.598
View more
  2 in total

Review 1.  Ventriculo-arterial decoupling in acutely altered hemodynamic states.

Authors:  Fabio Guarracino; Rubia Baldassarri; Michael R Pinsky
Journal:  Crit Care       Date:  2013-03-19       Impact factor: 9.097

2.  The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia.

Authors:  Lothar A Schwarte; Ingo Schwartges; Kai Thomas; Patrick Schober; Olaf Picker
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.